About Exforge

Hypertension will lead  to cardiovascular diseases such as stroke, blindness, kidney failure, heart failure and many more and it’s important to keep BP at target goal. New treatment strategies are needed.

Blood Pressure (BP) Aims: Your Bp should at least maintain to lower then 140/90 if you have no other complications.  This review analyses one of these strategies, which is the development of effective and safe combination therapy. Indeed, at least two antihypertensive agents are often needed to achieve blood pressure control. Exforge^® (Novartis) is a new drug combination of the calcium channel blocker, amlodipine, and the angiogenesis II receptor blocker, valsartan.   World wide known as Exforge.  With Exforge you could get your Bp Control better if your Bp not at goal despite treatment.

Doses Available: Exforgre 5/80 , Exforge 10/160 Exforge 5/160

Evidence review: The amlodipine/valsartan combination is an association of two well-known antihypertensive products with specific targets in cardiovascular protection, namely calcium channel blockade and antagonism of the renin-angiotensin-aldosterone system. This kind of association, with neutral metabolic properties and significant antihypertensive efficacy, could be a useful new antihypertensive product. Currently available data have shown that this new combination is well-tolerated and effective even in severe hypertension.

Clinical value: One of the Active compound Valsatran has been used in many Cardiovascular trials that prove to Reduce incidents of Heart failure, MI, Stroke, Regress Left Ventricular and improve in Renal safety hence prevented many Cardio events. With this new combination EXFORGE which will help you reduce BP at the same time is

Cardio Vascular protective to your hypertension management.